Table 2.
Candesartan | Telmisartan | Eprosartan | ||||
---|---|---|---|---|---|---|
Mutation | Ki (nM) | ΔKi | Ki (nM) | ΔKi | Ki (nM) | ΔKi |
N111G | 1.4 ± 0.5 | 1 | 38.8 ± 4.9 | 1 | 44.1 ± 6.1 | 1 |
N111G/V108I | 119 ± 19.0 | 85 | 627 ± 114 | 16.2 | 353 ± 36.4 | 8 |
N111G/S109T | 281 ± 57.5 | 201 | 268 ± 27.6 | 6.9 | 124 ± 17.1 | 2.8 |
N111G/A163T | 15.6 ± 4.9 | 11.1 | 4.0 ± 0.1 | 0.1 | 102 ± 10.5 | 2.3 |
N111G/E173A | 1.3 ± 0.2 | 0.9 | 51.4 ± 3.6 | 1.3 | 46.9 ± 8.0 | 1.1 |
N111G/F182A | 1.7 ± 0.6 | 1.2 | 11.1 ± 2.1 | 0.3 | 59.1 ± 10.1 | 1.3 |
N111G/Y184A | 1.2 ± 0.08 | 0.9 | 17.6 ± 2.8 | 0.5 | 87.4 ± 14.9 | 2.0 |
N111G/K199A | 148 ± 3.4 | 106 | 202 ± 11.6 | 5.2 | 334 ± 45.9 | 7.6 |
N111G/K199Q | 82.1 ± 11.3 | 58.6 | 205 ± 46.4 | 5.3 | 446 ± 91.1 | 10.1 |
N111G/H256A | 0.8 ± 0.2 | 0.6 | 47.0 ± 14.7 | 1.2 | 1262 ± 87 | 28.6 |
N111G/Q257A | 4.8 ± 0.7 | 3.4 | 66.0 ± 13.5 | 1.7 | 8061 ± 648 | 183 |
N111G/Q257E | 10.9 ± 5.3 | 7.8 | 258 ± 44.1 | 6.6 | 975 ± 284 | 22.1 |
N111G/Y292A | 0.005 ± 0.001 | 0.004 | 0.7 ± 0.2 | 0.02 | 44.7 ± 11.6 | 1 |
N111G/N295A | 6.7 ± 0.08 | 4.8 | 193 ± 30.9 | 5 | 360 ± 20.7 | 8.2 |
N111G/S109T/A163T | 310.0 ± 21.4 | 221 | 150 ± 15.5 | 3.9 | 153 ± 8.8 | 3.5 |
N111G/S109T/H256A | 168 ± 5.8 | 120 | 166 ± 24.7 | 4.3 | 1737 ± 258 | 39.4 |
N111G/S109T/N295A | 1274 ± 139 | 1231 | 449 ± 41.2 | 11.6 | 494 ± 95 | 11.2 |
N111G/A163T/H256A | 45.6 ± 17.5 | 32.6 | 19.0 ± 6.1 | 0.5 | 1410 ± 288 | 32 |
N111G/A163T/N295A | 20.2 ± 4.4 | 14.4 | 6.9 ± 1.8 | 0.2 | 541 ± 105 | 12.3 |
N111G/K199Q/H256A | 240 ± 5.5 | 171 | 209 ± 4.8 | 5.4 | 31 631 ± 728 | 717 |
N111G/H256A/N295A | 0.06 ± 0.02 | 0.04 | 19.5 ± 0.9 | 0.5 | 612 ± 49.2 | 13.9 |
Ligand‐binding properties of various mutants of N111G‐AT1 receptors. Values are presented as mean ± SEM of at least three independent experiments performed in duplicate. The effect of the mutations on the binding affinity is expressed as ΔKi = Ki (mutant)∕Ki (N111G‐AT1 receptor).